VeriSIM Life Secures $15 Million Series A Funding.

VeriSIM Life is on a mission to advance human health by accelerating drug development with AI-enabled technology.

We have developed a platform that enables AI-driven, bio-simulations that derisk drug research and development decisions by predicting the clinical outcomes of new drugs before human trials.